跳至主要内容
临床试验/NCT01053052
NCT01053052撤回不适用

A Comparative Study of Methods for Tubal Patency Determination and Uterine Cavity Evaluation: Sonography With the FemVue(TM) Catheter System vs. Hysterosalpingography (HSG)

Femasys Inc.0 个研究点开始时间: 2010年1月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
Femasys Inc.
主要终点
Concordance of evaluations of fallopian tube patency and intrauterine pathology.

研究概览

简要总结

Multi-center prospective comparison of fallopian tubal patency determination and uterine evaluation interventions using legally marketed devices for their intended purposes, and using each subject as their own control.

详细描述

Study cancelled prior to recruitment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Non-pregnant women between the ages of 18 and 45 who desire to know the patency status of the fallopian tubes and if the uterine cavity is free of pathology who have:
  • Been attempting conception for 6 months or
  • A history of PID (including the conditions listed below) or
  • Chlamydia
  • Gonorrhea
  • Endometriosis
  • A history of pelvic surgery or
  • Advanced maternal age (≥ 35) And
  • Negative test for Gonorrhea/Chlamydia or prophylactic antibiotic treatment
  • Without current bi-lateral tubal sterilization
  • Signed Informed Consent

排除标准

  • Uterine anomaly or lesion(s) preventing catheter placement for either the FemVue or HSG procedure(as identified and documented by TVUS Screening procedure or the uterine cavity evaluation during the FemVue procedure or any previous diagnostic procedure)
  • obstructing access to uterine cornu
  • distorting fundus at the midline region

结局指标

主要结局

Concordance of evaluations of fallopian tube patency and intrauterine pathology.

时间窗: Day 1

次要结局

  • subject discomfort assessment(Day 1)

研究者

发起方
Femasys Inc.
申办方类型
Industry
责任方
Sponsor

相似试验

Study of FemVue(TM) Sono Tubal Evaluation System... | 临床试验